Navigation Links
Bio-Identical Hormone Menopause Doctor Responds to Outrageous FDA News
Date:1/11/2008

FDA Warns Pharmacies Not to Compound Commonly-Prescribed Hormone Estriol,

Not to Use the Term 'Bio-identical'

SPOKANE, Wash., Jan. 11 /PRNewswire/ -- "The FDA statement regarding compounded estrogens -- which include estradiol and estriol -- progesterone, and other compounded hormones was very surprising to me and other medical experts in the field of Women's Hormones," remarks Cheryle Hart, M.D. She is Mayo Clinic trained and Board certified in Ob/Gyn and founded what is now Hormones by Hart in 1997. She is also the medical director of Hormones by Hart.

The FDA stated on January 9, 2008 that pharmacies cannot use the term "bio-identical" to describe the hormones they are compounding. "Even though the hormones they are using are actually chemically identical to what is produced by the human body," says Dr. Hart.

"I am astounded that the FDA does not recognize that estradiol, progesterone, testosterone, and DHEA are chemically identical to hormones found in our bodies, and are therefore bio-identical. I don't know what 'substantial evidence' they are waiting for to figure that one out."

According to their news release, the FDA does not approve of the use of the estrogen estriol in any compounded formula. They consider this the manufacture of an unapproved drug. "This is certainly news to me, since estriol is one of the types of hormones naturally found in a woman's body. For the FDA to say that menopausal women cannot benefit from the use of Estriol in HRT amazes me. I would certainly like the FDA to reconsider the published evidence on this estrogen and change their ruling," comments Dr. Hart.

Because of the misleading title of the FDA News release, Dr. Hart wants to reassure her patients that while it sounds like FDA is banning compounded bio-identical hormones, it is not banning the compounded hormones.

"It is really up to the compounding pharmacies and their organizations, PCCA and IACP to get th
'/>"/>

SOURCE Cheryle R. Hart, M.D.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Survival Data Presented From Phase II Study of Investigational Drug ZD4054 in Hormone-Resistant Prostate Cancer Patients
2. Video and Photo: EMD Serono Launches easypod(R), New Electronic Growth Hormone Injection Device
3. Patient Treatment for Bipolar Disorder Varies Depending on Doctor Specialty; Well Designed Clinical Trials May Be The Answer
4. Medical Breakthrough ... Doctor Discovers Penetrating Carrier That Eradicates Fungus
5. Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants
6. ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information
7. Updated Drug Development Scrip Report Responds to the Pharma Industrys Major Changes
8. Michigan Catholic Conference Responds to Formation of Embryonic Stem Cell Research Ballot Committee
9. GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes
10. CryoLife Responds to Inaccurate Assertions from Plaintiffs Attorney

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...ntly announced that Dr. Dominique Hebrault will pr...nalytical Technology (PAT) in Green Chemistry and ... (PRWEB) November 20, 2009 -...ology (PAT) in Green Chemistry and Green Engineeri...nology (PAT) case studies will be presented on how...
(Date:11/19/2009)...e/ -- Dr. Mate Hidvegi, inventor of Avemar ferment... issued on November 17 by Biropharma Kft, discredi...lf-serving statements about its U.S. competitor Am... his office in Budapest, Hungary: ,, "The Biro...y to AveULTRA, www.aveultra.com , is misleading...
(Date:11/19/2009)...., Nov. 19 Arlington Medical Resou...ading driver of antibiotic selection in nosocomial...ainst gram-positive and gram-negative pathogens. D...comial pneumonia, surveyed European physicians rev...de appropriate coverage against common pathogens, ...
(Date:11/19/2009)...nthesis Companies Form International Gene Synthesi...n Risk Reduction ,Five Member Companies Represen... , (PRWEB) November 19, 20...esis companies today announced agreement that they... biosecurity in the gene synthesis industry. By s...
Breaking Biology Technology:Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4
...ate vaccines for avian flu through genet...CKVILLE, Md., Nov. 13 Novavax, Inc.,(Nasdaq: NVA... avian flu,through genetically-engineered virus-li...tion at Cleveland Clinic 6th Annual Medical Innova...initiatives have the potential to,impact millions ...
... Genaera,Corporation (Nasdaq: GENR ) will presen...the Congress Center in Mannheim, Germany. Dr. Henr...ific Officer, will present,a company overview on T...ut Genaera, Genaera Corporation is developing tro...ity currently in phase 1 clinical testing and has ...
...nta Holding,Corporation (NYSE: CVA ), a world lea...rgy-from-Waste and renewable energy facilities, to... purchase two biomass energy,facilities from co-ow...vices, Inc., Pursuant to the amended agreement, C...for approximately $52 million subject to working c...
Other Biology Technology:Cleveland Clinic Recognizes New Strategies for Creating Vaccines for Avian Flu as a Top Ten Medical Innovation for 2009 2Cleveland Clinic Recognizes New Strategies for Creating Vaccines for Avian Flu as a Top Ten Medical Innovation for 2009 3Cleveland Clinic Recognizes New Strategies for Creating Vaccines for Avian Flu as a Top Ten Medical Innovation for 2009 4Genaera to Present at BIO-Europe 2008 2Covanta Announces Amended Terms for its Acquisition of Two Biomass Energy Facilities in Maine 2Covanta Announces Amended Terms for its Acquisition of Two Biomass Energy Facilities in Maine 3Covanta Announces Amended Terms for its Acquisition of Two Biomass Energy Facilities in Maine 4
(Date:11/23/2009)...e in German . , Not just birds, but also a .... Researchers at Princeton University in the U.S. ... Radolfzell, Germany studied the migratory behavio...lled "Vespertilionidae" with the help of mathemati...r short as well as long distances of various kinds...
(Date:11/22/2009)...cientists have inventoried an astonishing abundanc...that have never known sunlight - creatures that so... to 5,000 meters (~3 miles) below the ocean waves....ther vanguard technologies, animals known to thriv... a diverse collection of species ranging from crab...
(Date:11/22/2009)...esearch Centre, a partnership of the University of...r Coastal Health Research Institute, have uncovere...in cells die following a stroke, as well as a poss...he study were recently published online in Nature...ls continue to die even after blood flow has been ...
Breaking Biology News(10 mins):We're off then: The evolution of bat migration 2Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 2Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 3Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 4Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 5Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 6Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 7Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 8Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 9New understanding about mechanism for cell death after stroke leads to possible therapy 21 in 4 nursing home residents carry MRSA 47915 11 in 4 nursing home residents carry MRSA 47915 2New Option for Erasing Wrinkles 47913 1New Option for Erasing Wrinkles 47913 2New Option for Erasing Wrinkles 47913 3New Option for Erasing Wrinkles 47913 4Keys to a Fit Pregnancy and Losing the Baby Weight 47910 1Keys to a Fit Pregnancy and Losing the Baby Weight 47910 2Keys to a Fit Pregnancy and Losing the Baby Weight 47910 3
...s discovered a new ultra-small species of bacteria...hin the ice of a Greenland glacier at a depth of n...ersist in this low-temperature, high-pressure, red...rticularly useful for studying how life, in genera...s on Earth and possibly elsewhere in the solar sys...
...m among scientists has long been that birds acquir...ood health from their environment, but a new Unive...ually born with those bacteria. , Lead author Adr... at the American Society for Microbiology General ...ns for the poultry industry and for food safety. ,...
... commonplace everyday events than meets the eye. T...m a tap, are two such events, both of which involv...cated mathematical techniques to describe, analyse...in common between many such singular events across...actions to the very formation of the universe itse...
Other Biology News:A survivor in Greenland: A novel bacterial species is found trapped in 120,000-year-old ice 2Study finds healthy intestinal bacteria within chicken eggs 2Finding out what the Big Bang and ink jets have in common 2Finding out what the Big Bang and ink jets have in common 3
Direct ELISA Assay Diluent from BioFX Laboratories, Inc.
Direct ELISA Assay Diluent - EDTA from BioFX Laboratories, Inc.
Rabbit Anti-Mouse Junctophilin-4, C-Terminus Monoclonal Antibody, Unconjugated, Clone PADZMD.487 from Invitrogen
Fluorescence Preserving Media from BioFX Laboratories, Inc.
Biology Products: